The cellular and molecular processes associated with scopolamine-induced memory deficit: A model of Alzheimer's biomarkers

Research output: Contribution to journalReview ArticleOtherpeer-review

79 Citations (Scopus)


Alzheimer's disease (AD) is neurodegenerative disorder that is associated with memory and cognitive decline in the older adults. Scopolamine is commonly used as a behavioral model in studying cognitive disorders including AD. Many studies have also concurrently examined the neurochemical mechanisms underlying the behavioral modifications by scopolamine treatment. Nonetheless, the scopolamine model has not become a standard tool in the early assessment of drugs. Furthermore, the use of scopolamine as a pharmacological model to study AD remains debatable. This report reviews the scopolamine-induced cellular and molecular changes and discusses how these changes relate to AD pathogenesis.

Original languageEnglish
Article number116695
Number of pages6
JournalLife Sciences
Publication statusPublished - 15 Sept 2019


  • Alzheimer's disease
  • Amyloid beta-peptides
  • Apoptosis
  • Dementia
  • Inflammation
  • Oxidative stress
  • Scopolamine
  • Tau proteins

Cite this